FRG Family Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$570K Sell
20,298
-5,437
-21% -$145K 0.09% 109
2025
Q4
$641K Sell
25,735
-114
-0.4% -$2.88K 0.1% 105
2025
Q3
$659K Sell
25,849
-1,100
-4% -$27.1K 0.11% 102
2025
Q2
$653K Sell
26,949
-2,560
-9% -$59.7K 0.11% 95
2025
Q1
$748K Sell
29,509
-15,006
-34% -$393K 0.14% 92
2024
Q4
$1.18M Hold
44,515
0.21% 70
2024
Q3
$1.29M Buy
44,515
+165
+0.4% +$4.81K 0.23% 67
2024
Q2
$1.3M Sell
44,350
-6,360
-13% -$175K 0.25% 63
2024
Q1
$1.3M Sell
50,710
-7,570
-13% -$210K 0.25% 61
2023
Q4
$1.68M Sell
58,280
-10,822
-16% -$327K 0.34% 50
2023
Q3
$2.29M Sell
69,102
-685
-1% -$24.2K 0.52% 41
2023
Q2
$2.56M Sell
69,787
-4,921
-7% -$192K 0.56% 37
2023
Q1
$3.05M Sell
74,708
-2,305
-3% -$99.6K 0.7% 37
2022
Q4
$3.95M Sell
77,013
-3,170
-4% -$152K 0.94% 32
2022
Q3
$3.51M Buy
80,183
+925
+1% +$44.9K 0.87% 31
2022
Q2
$4.16M Hold
79,258
0.96% 30
2022
Q1
$4.1M Buy
79,258
+100
+0.1% +$5.19K 0.8% 33
2021
Q4
$4.67M Sell
79,158
-200
-0.3% -$9.91K 0.87% 30
2021
Q3
$3.41M Sell
79,358
-2,402
-3% -$106K 0.67% 34
2021
Q2
$3.2M Sell
81,760
-1,135
-1% -$44.1K 0.61% 37
2021
Q1
$3M Sell
82,895
-1,033
-1% -$36.7K 0.61% 39
2020
Q4
$3.09M Sell
83,928
-5,038
-6% -$185K 0.67% 38
2020
Q3
$3.1M Sell
88,966
-2,076
-2% -$72.8K 0.75% 37
2020
Q2
$2.83M Sell
91,042
-512
-0.6% -$17.4K 0.75% 39
2020
Q1
$2.83M Sell
91,554
-5,371
-6% -$183K 0.86% 34
2019
Q4
$3.6M Sell
96,925
-13,059
-12% -$465K 0.87% 33
2019
Q3
$3.75M Buy
109,984
+6,229
+6% +$227K 0.97% 33
2019
Q2
$4.26M Buy
103,755
+1,239
+1% +$49.2K 1.12% 28
2019
Q1
$4.13M Buy
102,516
+1,412
+1% +$56.5K 1.17% 26
2018
Q4
$4.19M Buy
101,104
+4,074
+4% +$169K 1.37% 18
2018
Q3
$4.06M Buy
97,030
+8,843
+10% +$340K 1.11% 23
2018
Q2
$3.04M Buy
88,187
+6,935
+9% +$237K 0.91% 31
2018
Q1
$2.74M Buy
81,252
+2,870
+4% +$98.7K 0.91% 39
2017
Q4
$2.69M Buy
78,382
+711
+0.9% +$24.2K 0.87% 43
2017
Q3
$2.63M Buy
77,671
+126
+0.2% +$4.05K 0.91% 39
2017
Q2
$2.47M Buy
77,545
+1,192
+2% +$37.6K 0.91% 39
2017
Q1
$2.49M Buy
76,353
+2,951
+4% +$93K 0.97% 36
2016
Q4
$2.26M Buy
73,402
+1,989
+3% +$60.7K 0.95% 36
2016
Q3
$2.29M Buy
71,413
+1,033
+1% +$34.5K 1.03% 32
2016
Q2
$2.35M Buy
70,380
+2,929
+4% +$93.5K 1.06% 30
2016
Q1
$1.92M Buy
67,451
+606
+0.9% +$17.3K 0.93% 37
2015
Q4
$2.05M Buy
+66,845
New +$2.1M 1% 34

Other funds holding PFE

FRG Family Wealth Advisors's PFE Position: Q1 2026 in Review

FRG Family Wealth Advisors reduced its Pfizer (PFE) stake by 21% in Q1 2026, selling an estimated $145K and leaving 20,298 shares worth $570K. The position accounts for 0.09% of the portfolio, ranked #109.

FRG Family Wealth Advisors first reported a position in PFE in Q4 2015 and has held it in 42 quarters since. The position peaked at $4.67M in Q4 2021. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • FRG Family Wealth Advisors held 20,298 shares of Pfizer worth $570K as of Q1 2026.
  • FRG Family Wealth Advisors sold 5,437 Pfizer shares in Q1 2026, an estimated $145K.
  • Pfizer made up 0.09% of FRG Family Wealth Advisors's portfolio in Q1 2026, its #109 holding.
  • FRG Family Wealth Advisors first reported a position in Pfizer in Q4 2015 and has held it in 42 quarters since.
  • FRG Family Wealth Advisors's Pfizer position peaked at $4.67M in Q4 2021.
  • 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on FRG Family Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.